ACKR3 and cancer: Because inhibiting CXCR4 or CXCR7 only on 231-control cancer cells did not affect adhesion, these data further emphasize that basal treatment with CXCL12 acts through endothelial CXCR4 to significantly enhance adhesion of circulating cancer cells.